These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33883369)

  • 41. Proton MR spectroscopy of normal breasts: Association of risk factors for breast cancer with water and lipid composition of the breast.
    Wang J; Wang MY; Kuo WH; Chen KL; Shih TT
    Magn Reson Imaging; 2016 May; 34(4):524-8. PubMed ID: 26712654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved Diagnostic Accuracy in Characterization of Adnexal Masses by Detection of Choline Peak Using 1H MR Spectroscopy in Comparison to Internal Reference at 3 Tesla.
    Malek M; Pourashraf M; Gilani MM; Gity M
    Asian Pac J Cancer Prev; 2015; 16(12):5085-8. PubMed ID: 26163646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton MR spectroscopy in the breast: Technical innovations and clinical applications.
    Fardanesh R; Marino MA; Avendano D; Leithner D; Pinker K; Thakur SB
    J Magn Reson Imaging; 2019 Oct; 50(4):1033-1046. PubMed ID: 30848037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Everyman's prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy.
    Mueller-Lisse UG; Murer S; Mueller-Lisse UL; Kuhn M; Scheidler J; Scherr M
    Eur Radiol; 2017 Aug; 27(8):3362-3371. PubMed ID: 28058480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
    Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Preliminary Study on the Diagnostic Efficacy of Proton Magnetic Resonance Spectroscopy at 3.0T in Rabbit With VX2 Liver Tumor.
    Liao R; Zhang D; Li X; Ma J; Yu J; Yang C; Xiong H; Zhou B; Huang X; Tang Z
    Technol Cancer Res Treat; 2021; 20():15330338211036852. PubMed ID: 34372732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
    Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
    NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T.
    Baik HM; Su MY; Yu H; Mehta R; Nalcioglu O
    MAGMA; 2006 May; 19(2):96-104. PubMed ID: 16779565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility of 7 Tesla breast magnetic resonance imaging determination of intrinsic sensitivity and high-resolution magnetic resonance imaging, diffusion-weighted imaging, and (1)H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy.
    Korteweg MA; Veldhuis WB; Visser F; Luijten PR; Mali WP; van Diest PJ; van den Bosch MA; Klomp DJ
    Invest Radiol; 2011 Jun; 46(6):370-6. PubMed ID: 21317792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
    J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of J coupling and T2 Relaxation in Assessing of Methyl Lactate Signal using PRESS Sequence MR Spectroscopy.
    Isobe T; Matsumura A; Anno I; Kawamura H; Muraishi H; Umeda T; Nose T
    Igaku Butsuri; 2005; 25(2):68-74. PubMed ID: 16135894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil.
    Gribbestad IS; Singstad TE; Nilsen G; Fjøsne HE; Engan T; Haugen OA; Rinck PA
    J Magn Reson Imaging; 1998; 8(6):1191-7. PubMed ID: 9848727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Qualitative 3-T Proton MR Spectroscopy for the Characterization of Musculoskeletal Neoplasms: Update on Diagnostic Performance and Indications.
    Gondim Teixeira PA; Ledrich M; Kauffmann F; Wamba JM; Felblinger J; Blum A; Hossu G
    AJR Am J Roentgenol; 2017 Jun; 208(6):1312-1319. PubMed ID: 28301222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ¹H-magnetic resonance spectroscopy of the breast at 3.0-T: comparison of results obtained before and after administration of gadolinium-based contrast agent.
    Kawai H; Naganawa S; Satake H; Ishigaki S; Sakurai Y; Mori M; Maruyama K
    J Magn Reson Imaging; 2012 Mar; 35(3):717-22. PubMed ID: 22095613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of spectral selected press sequence in breast lesion characterization.
    Lu H; Liu PF; Bao RX; Sun F
    Chin Med Sci J; 2006 Dec; 21(4):265-9. PubMed ID: 17249203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion weighted MRI and spectroscopy in invasive carcinoma of the breast at 3Tesla. Correlation with dynamic contrast enhancement and pathologic findings.
    Boulogianni G; Chryssogonidis I; Drevelegas A
    Hippokratia; 2016; 20(3):192-197. PubMed ID: 29097884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
    Bolan PJ; Meisamy S; Baker EH; Lin J; Emory T; Nelson M; Everson LI; Yee D; Garwood M
    Magn Reson Med; 2003 Dec; 50(6):1134-43. PubMed ID: 14648561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility of MR spectroscopy for characterizing malignant breast lesions using a clinical 3-T scanner.
    Baek HM; Lee YJ
    Breast Cancer; 2015 Sep; 22(5):510-9. PubMed ID: 24390858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching.
    Scheidler J; Vogel M; Gross P; Heuck A
    Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
    Yeung DK; Yang WT; Tse GM
    Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.